PECAM-1: Old friend, new partners

Current Opinion in Cell Biology

Volumn 15, Issue 5, 2003, Pages 515-524

  Ilan, Neta ^a   Madri, Joseph A ^b  

^a TECHNION ISRAEL INSTITUTE OF TECHNOLOGY   (Israel)

^b YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CATENIN; CD31 ANTIGEN; STAT PROTEIN;

ANTIGEN FUNCTION; APOPTOSIS; EPITHELIUM; HUMAN; MESENCHYME; MOLECULAR DYNAMICS; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN FAMILY; PROTEIN INTERACTION; PROTEIN PHOSPHORYLATION; REVIEW; SIGNAL TRANSDUCTION; SRC HOMOLOGY DOMAIN;

EID: 0141867737     PISSN: 09550674     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0955-0674(03)00100-5     Document Type: Review

References (76)

1. Newman P., Hillery C., Albrecht R., Parise L., Berndt M., Mazurov A., Dunlop L., Zhang J., Rittenhouse S. Activation-dependent changes in human platelet PECAM-1: phosphorylation, cytoskeletal association, and surface membrane redistribution. J Cell Biol. 119:1992;239-246.
2. Lu T., Yan L.G., Madri J.A. Integrin engagement mediates tyrosine dephosphorylation on platelet-endothelial cell adhesion molecule 1. Proc Natl Acad Sci USA. 93:1996;11808-11813.
3. Jackson D.E., Ward C.M., Wang R., Newman P.J. The protein-tyrosine phosphatase SHP-2 binds platelet/endothelial cell adhesion molecule-1 (PECAM-1) and forms a distinct signaling complex during platelet aggregation. J Biol Chem. 272:1997;6986-6993.
4. Jackson D.E., Kupcho K.R., Newman P.J. Characterization of phosphotyrosine binding motifs in the cytoplasmic domain of platelet/ endothelial cell adhesion molecule -1 (PECAM-1) that are required for the cellular association and activation of the protein-tyrosine phosphatase, SHP-2. J Biol Chem. 272:1997;24868-24875.
5. lck. Blood. 97:2001;2351-2357.
6. Sagawa K., Kimura T., Swieter M., Siraganian R.P. The protein-tyrosine phosphatase SHP-2 associates with tyrosine-phosphorylated adhesion molecule PECAM-1(CD31). J Biol Chem. 272:1997;31086-31091.
7. Ji G., O'Brien C.D., Feldman M., Manevich Y., Lim P., Sun J., Albelda S.M., Kotlikoff M.I. PECAM-1 (CD31) regulates a hydrogen peroxide-activated nonselective cation channel in endothelial cells. J Cell Biol. 157:2002;173-184.
8. Masuda M., Osawa M., Shigematsu N., Hadara N., Fujiwara K. Platelet endothelial cell adhesion molecule 1 is a major SH-PTP2 binding protein in vascular endothelial cells. FEBS Lett. 408:1997;331-336.
9. Osawa M., Masuda M., Harada N., Lopes R.B., Fujiwara K. Tyrosine phosphorylation of platelet endothelial cell adhesion molecule 1 (PECAM-1, CD31) in mechanostimulated vascular endothelial cells. Eur J Cell Biol. 72:1997;229-237.
10. Osawa M., Masuda M., Kusano K.-I., Fujiwara K. Evidence for a role of platelet endothelial cell adhesion molecule 1 and phosphoinositide 3-kinase in human neutrophils. J Cell Biol. 158:2002;1-13 In this report the authors, using fluid-shear stress, hyperosmotic shock and anti-PECAM-1-coated magnetic beads, demonstrate PECAM-1 and ERK phosphorylation and PECAM-1/SHP-2 binding and suggest that in addition to its other functions PECAM-1 may function as a mechanotransducer, affecting pivotal signaling cascades.
11. Pinter E., Barreuther M., Lu T., Imhof A., Madri J.A. Platelet-endothelial cell adhesion molecule 1 (PECAM-1/CD31) tyrosine phosphorylation state changes during vasculogenesis in the murine conceptus. Am J Pathol. 150:1997;1523-1530.
12. Pinter E., Mahooti S., Wang Y., Imhof B.A., Madri J.A. Hyperglycemia-induced vasculopathy in the murine vitelline vasculature: correlation with PECAM-1/CD31 tyrosine phosphorylation state. Am J Pathol. 154:1999;1367-1379.
13. Lu T.T., Barreuther M., Davis S., Madri J.A. Platelet endothelial cell adhesion molecule-1 is phosphorylatable by c-Src, binds Src-Src homology 2 domain, and exhibits immunoreceptor tyrosine-based activation-motif-like properties. J Biol Chem. 272:1997;14442-14446.
14. Cao M.Y., Huber M., Beauchemin N., Famiglietti J., Albelda S.M., Veillette A. Regulation of mouse PECAM-1 tyrosine phosphorylation by the Src and Csk families of protein-tyrosine kinases. J Biol Chem. 273:1998;15765-15772.
15. Ilan N., Cheung L., Pinter E., Madri J.A. PECAM-1 (CD31): A scaffolding molecule for selected catenin family members whose binding is mediated by different tyrosine and serine/threonine phosphorylation. J Biol Chem. 275:2000;21435-21443.
16. Pellegatta F., Chierchia S.L., Zocchi M.R. Functional association of platelet endothelial cell adhesion molecule 1 and phosphoinositide 3-kinase in human neutrophils. J Biol Chem. 273:1998;27768-27771.
17. Pumphrey N.J., Taylor V., Freeman S., Douglas M.R., Bradfield P.F., Young S.P., Lord J.M., Wakelam M.J.O., Bird I.N., Salmon M.et al. Differential association of cytoplasmic signaling molecules SHP-1, SHP-2, SHIP and phospholipase C-γ1 with PECAM-1/CD31. FEBS Lett. 450:1999;77-83.
18. Lanier L.L. On guard-activating NK cell receptors. Nat Immunol. 2:2001;23-27.
19. Newman P. Switched at birth: a new family for PECAM-1. J Clin Invest. 103:1999;5-9.
20. Tomasello E., Blery M., Vely F., Vivier E. Signaling pathways engaged by NK cell receptors: double concerto for activating receptor, inhibitory receptors and NK cells. Semin Immunol. 12:2000;139-147.
21. Newton-Nash D.K., Newman P.J. A new role for platelet-endothelial cell adhesion molecule 1 (CD31): inhibition of TCR-mediated signal transduction. J Immunol. 163:1999;682-688.
22. Henshall T.L., Jones K.L., Wilkinson R., Jackson D. Src homology 2 domain-containing protein-tyrosine phosphatases, SHP-1 and SHP-2, are required for platelet endothelial cell adhesion molecule-1/CD31-mediated inhibitory signaling. J Immunol. 16:2001;3098-3106.
23. Patil S., Newman D.K., Newman P.J. Platelet endothelial adhesion molecule 1 serves as inhibitory receptor that modulates platelet responses to collagen. Blood. 97:2001;1727-1732.
24. Cicmil M., Thomas J.M., Leduc M., Bon C., Gibbins J.M. Platelet endothelial cell adhesion molecule 1 signaling inhibits the activation of human platelets. Blood. 99:2002;137-144.
25. Elias C.G., Spellberg J.P., Karan-Tamir B., Lin C.-H., Wang Y.-J., McKenna P.J., Muller W.A., Zukowski M.M., Andrew D.P. Ligation of CD31/PECAM-1 modulates the function of lymphocytes, monocytes and neutrophils. Eur J Immunol. 28:1998;1948-1958.
26. Gratzinger D., Barreuther M., Madri J. Platelet-endothelial cell adhesion molecule 1 modulates endothelial migration through its immunoreceptor tyrosine-based inhibitory motif. Biochem Biophys Res Commun. 301:2003;243-249 In this report the authors demonstrate that differential phosphorylation of PECAM-1 tyrosine residues Y663 and Y686 was associated with distinct SHP-2-binding and catalytic activities as well as with cellular localization. PECAM-1's interaction with SHP-2 was also found to influence SHP-2's substrate specificity, including tyrosine-phosphorylated β-catenin and FAK, thus affecting endothelial migration.
27. Freeman R.M., Plutzky J., Neel B.G. Identification of a human src-homology-2-containing protein tyrosine phosphatase: a putative homologue of Drosophila corkscrew. Proc Natl Acad Sci USA. 89:1992;11239-11243.
28. Perkins L.A., Larsen I., Perrimon N. Corkscrew encodes a putative protein tyrosine phosphatase that functions to transduce the terminal signal from the receptor tyrosine kinase torso. Cell. 70:1992;225-236.
29. Stein-Gerlach M., Wallasch C., Ullrich A. SHP-2, SH2-containing protein tyrosine phosphatase 2. Int J Biochem Cell Biol. 30:1998;559-566.
30. Ilan N., Mahooti S., Rimm D.L., Madri J.A. PECAM-1 (CD31) functions as a reservoir for and a modulator of tyrosine-phosphorylated β-catenin. J Cell Sci. 112:1999;3005-3014.
31. Ilan N., Mohsenin A., Cheung L., Madri J.A. PECAM-1 shedding during apoptosis generates a membrane-anchored truncated molecule with unique signaling characteristics. FASEB J. 15:2001;362-372.
32. Cochrane D., Wester C., Masih G., McCafferty J. Identification of natural ligand for SH2 domains from a phage display cDNA library. J Mol Biol. 297:2000;89-97.
33. Birchmeier C., Birchmeier W., Brand-Saberi B. Epithelial-mesenchymal transition in cancer progression. Acta Anat. 156:1996;217-226.
34. Daniel J., Reynolds A. Tyrosine phosphorylation and cadherin/catenin function. Biol Essays. 19:1997;883-891.
35. Provost E., Rimm D.L. Controversies at the cytoplasmic face of the cadherin-based adhesion complex. Curr Opin Cell Biol. 11:1999;567-572.
36. Schroeder J.A., Adriance M.C., McConnell E.J., Thompson M.C., Pockaj B., Gendler S.J. ErbB-β-catenin complexes are associated with human infiltrating ductal breast and murine mammary tumor virus (MMTB)-wnt-1 and MMTY-c-Neu transgenic carcinomas. J Biol Chem. 277:2002;22692-22698.
37. Roura S., Miravet S., Piedra J., de Herreros A.G., Dunach M. Regulation of E-cadherin/catenin association by tyrosine phosphorylation. J Biol Chem. 274:1999;36734-36740.
38. Piedra J., Martinez D., Castano J., Miravet S., Dunach M., de Herreros A.G. Regulation of β-catenin structure and activity phosphorylation. J Biol Chem. 276:2001;20436-20443.
39. Bienz M., Clevers H. Linking colorectal cancer to Wnt signaling. Cell. 103:2000;311-320.
40. Matsumura T., Wolff K., Petzelbauer P. Endothelial cell tube formation depends on cadherin 5 and CD31 interactions with filamentous actin. J Immunol. 158:1997;3408-3416.
41. Abedi H., Zachary I. Vascular endothelial growth factor stimulates tyrosine phosphorylation and recruitment to new focal adhesions of focal adhesion kinase and paxillin in endothelial cells. J Biol Chem. 273:1997;15442-15451.
42. Esser S., Lampugnani M., Corada M., Dejana E., Risau W. Vascular endothelial growth factor induces VE-cadherin tyrosine phosphorylation in endothelial cells. J Cell Sci. 111:1998;1853-1865.
43. ••].
44. Wang Y., Su X., Sorenson C.M., Sheibani N. Tissue-specific distributions of alternatively spliced human PECAM-1 isoforms. Am J Physiol Heart Circ Physiol. 284:2003;H1008-H1017 These two papers demonstrate the complex, partially species-specific alternative splicing patterns observed in the cytoplasmic domain of PECAM-1 during development and differentiation. Interestingly, the alternatively spliced exons (12-15) correspond to those mediating SHP-2, src family member, β- and γ-catenin and STAT family member interactions.
45. Nawroth R., Poell G., Ranft A., Kloep S., Samulowitz U., Fachinger G., Golding M., Shima D.T., Deutsch U., Vestweber D. VE-PTP and VE-cadherin ectodomains interact to facilitate regulation of phosphorylation and cell contacts. EMBO J. 21:2002;4885-4895.
46. Taddei M.L., Chiarugi P., Cirri P., Buricchi F., Fiaschi T., Giannoni E., Taliani D., Cozzi G., Formigli L., Raugei G.et al. β-catenin interacts with low-molecular-weight protein tyrosine phosphatase leading to cadherin-mediated cell-cell adhesion increase. Cancer Res. 62:2002;6489-6499.
47. Graesser D., Solowiej A., Bruckner M., Osterweil E., Judes A., Davis S., Ruddle N., Engelhardt B., Madri J.A. Changes in vascular permeability and early onset of experimental autoimmune encephalomyelitis in PECAM-1 (CD31) deficient mice. J Clin Invest. 109:2002;383-392.
48. Ayalon O., Sabani H., Lampugnani M.-G., Dejana E., Geiger B. Spatial and temporal relationship between cadherin and PECAM-1 in cell-cell junctions of human endothelial cells. J Cell Biol. 126:1994;247-258.
49. Brown S., Heinisch I., Ross E., Shaw K., Buckley C., Savill J. Apoptosis disables CD31-mediated cell detachment from phagocytes promoting binding and engulfment. Nature. 418:2002;200-203 In this report the authors propose that PECAM-1 functions to prevent tethering to and ingestion by phagocytes of intimately apposed viable leukocytes; however, this PECAM-1 repulsive function appears to be disabled in apoptotic leukocytes, allowing macrophage ingestion of apoptotic cells.
50. Ilan N., Cheung L., Miller S., Mohsenin A., Tucker A., Madri J.A. PECAM-1 is a modulator of stat family member phosphorylation and localization: lessons from a transgenic mouse. Dev Biol. 232:2001;219-232.
51. Groner B., Hennighausen L. Linear and cooperative signaling: roles for Stat proteins in the regulation of cell survival and apoptosis in the mammary epithelium. Breast Can Res. 2:2000;149-153.
52. Bartoli M., Gu X., Tsai N.T., Venema R.C., Brooks S.E., Marrero M.B., Caldwell R.B. Vascular endothelial growth factor activates STAT proteins in aortic endothelial cells. J Biol Chem. 275:2000;33189-33192.
53. Alon T., Hemo I., Itin A., Peer J., Stone J., Keshet E. Vascular endothelial growth factor acts as a survival factor for newly formed retinal vessels and has implications for retinopathy of prematurity. Nat Med. 1:1995;1024-1028.
54. Benjamin L.E., Golijanin D., Itin A., Pode D., Keshet E. Selective ablation of immature blood vessels in established human tumors follows vascular endothelial growth factor withdrawal. J Clin Invest. 103:1999;159-165.
55. Ilan N., Mahooti S., Madri J.A. Distinct signal transduction pathways are utilized during the tube formation and survival phases of in vitro angiogenesis. J Cell Sci. 111:1998;3621-3631.
56. Scatena M., Giachelli C. The αvβ3 integrin, NF-κB osteoprotegerin, endothelial cell survival pathway. Potential role in angiogenesis. Trends Cardiovasc Med. 12:2002;83-88.
57. Carmeliet P., Lampugnani M.-G., Moons L., Breviario F., Compernolle V., Bono F., Balconi G., Spagnuolo R., Oosthuyse B., Dewerchin M.et al. Targeted deficiency or cytosolic truncation of the VE-cadherin gene in mice impairs VEGF-mediated endothelial survival and angiogenesis. Cell. 98:1999;147-157.
58. Bird I.N., Taylor V., Newton J.P., Spragg J.H., Simmons D.L., Salomon M., Buckley C.D. Hemophilic PECAM-1 (CD31) interactions prevent endothelial cell apoptosis but do not support cell spreading or migration. J Cell Sci. 112:1999;1989-1997.
59. Evans P.C., Taylor E.R., Kilshaw P.J. Signaling through CD31 protects endothelial cells from apoptosis. Transplantation. 71:2001;457-460.
60. + leukocyte precursors following transendothelial migration. In addition, they demonstrate a PECAM-1 activation of the Akt/PKB pathway and the induction of the anti-apoptotic proteins Bcl-2 A1 and BCl-X.
61. Nobel K.E., Wickremasinghe R.G., DeCornet C., Panayiotidis P., Yong K.L. Monocytes stimulate expression of the Bcl-2 family member, A1, in endothelial cells and confer protection against apoptosis. J Immunol. 162:1999;1376-1383.
62. Serebruany V.L., Murugesan S.R., Pothula A., Semaan H., Gurbel P.A. Soluble PECAM-1, but not P-selectin nor osteonectin, identify acute myocardial infraction in patients with chest pain. Cardiology. 9:1999;50-55.
63. Zaremba L., Losy J. sPECAM-1 in serum and CSF of acute ischemic stroke patients. Acta Neurol Scand. 106:2002;292-298 In this report the authors document an increased level of soluble PECAM-1 in the sera of patients suffering from acute ischaemic stroke. In light of the reports of Laio et al. [64-66], this observed increase in soluble PECAM-1 (possibly due to enzymatic cleavage and shedding) may be playing a significant role in the regulation of the inflammatory responses initiated by this and other disease states.
64. Losy J., Niezgoda A., Wender M. Increased serum levels of soluble PECAM-1 in multiple sclerosis patients with brain gadolinium-enhancing lesions. J Neuroimmunol. 99:1999;169-172.
65. Liao F., Ali J., Greene T., Muller W.A. Soluble domain 1 of platelet-endothelial cell adhesion molecule (PECAM) is sufficient to block transendothelial cell migration invitro and in vivo. J Exp Med. 185:1997;1349-1357.
66. Liao F., Schenkel A.R., Muller W.A. Transgenic mice expressing different levels of soluble platelet/endothelial-cell-adhesion-molecule-lgG display distinct inflammatory phenotypes. J Immunol. 163:2000;5640-5648.
67. Hakak Y., Hsu Y.S., Martin G.S. SHP-2 mediates v-Src-induced morphological changes and activation of the anti-apoptotic protein kinase Akt. Oncogene. 19:2000;3164-3171.
68. Wu C.-J., O'Rourke D.M., Feng G.-S., Johnson G.R., Wang Q., Greene M.I. The tyrosine phosphatase SHP-2 is required for mediating phosphatidylinositol-3-kinase/Akt activation by growth factors. Oncogene. 20:2001;6018-6025.
69. Enciso J., Gratzinger D., Canosa S., Camenisch T.D., Pinter E., Madri J.A. Elevated glucose inhibits VEGF-mediated endocardial cushion formation: modulation by PECAM-1 and MMP-2. J Cell Biol. 160:2003;605-625 In this report the authors demonstrate a role for PECAM-1 as a modulator of EMT in the developing cardiac cushion. PECAM-1 expression was found to affect the ability of endocardial cells to effectively migrate into the underlying cardiac jelly, probably by affecting cell-cell adhesion and MMP-2 expression.
70. Miquerol L., Langille B., Nagy A. Embryonic development is disrupted by modest increases in vascular endothelial growth factor gene expression. Development. 127:2000;3941-3946.
71. Pinter E., Haigh J., Nagy A. Hyperglycemia-induced vasculopathy in the murine conceptus is mediated via reductions of VEGF expression and VEGF receptor activation. Am J Pathol. 158:2001;1199-1206.
72. Ara T., Deyama Y., Yoshimura Y., Higashino F., Shindoh M., Matsumoto A., Fukuda H. Membrane type-1-matrix metalloproteinase expression is regulated by E-cadherin through the suppression of mitogen-activated protein kinase cascade. Cancer Lett. 157:2000;115-121.
73. Yokoyama K., Kamata N., Fujimoto R., Tsutsumi S., Tomonari M., Taki M., Hosokawa H., Nagayama M. Increased invasion and matrix metalloproteinase-2 expression by snail-induced mesenchymal transition in squamous cell carcinomas. J Oncol. 22:2003;891-898.
74. Gao C, Sun W, Christofidou-Solomidou M, Sawada M, Newman DK, Bergom C, Albelda SM, Matsuyama S, Newman PJ: PECAM-1 functions as a specific and potent inhibitor of mitochondrial-dependent apoptosis. Blood 2003, in press.
75. Mamdouh Z., Chen X., Pierini L.M., Maxfield F.R., Mullter W.A. Targeted recycling of PECAM from endothelial surface-connected compartments during diapedesis. Nature. 421:2003;748-753 In this report the authors demonstrate that, in addition to its cell surface localization at cell-cell borders, endothelial PECAM-1 also resides in a membrane network just below the plasmalemma. During the transendothelial migration of leukocytes, this membranous network provides the migrating leukocytes with sufficient PECAM-1/PECAM-1 interaction sites during transmigration and is recycled to this compartment once transmigration is complete.
76. Gratzinger D, Canosa S, Engelhardt B, Madri JA: Platelet endothelial cell adhesion molecule-1 modulates endothelial cell motility through the small G-protein Rho. FASEB J 2003, in press.